Skip to main navigation
  • Contact Us
  • Investors
  • Media
  • Careers
    •
  • About Us
    • COVID-19
    • See the Difference
    • Leadership
    • Board of Directors
    • History
    • Grants
    • Locations
  • Products
    • Overview Overview
      • DEFINITY ®
        • VIALMIX ®
        • PINSYNC ®
      • PYLARIFY
      • TechneLite ®
      • Xenon-133
        • Calidose™ Dispenser System
      • AZEDRA ®
      • NEUROLITE ®
      • Thallium-201
      • Cardiolite ®
      • Gallium-67
    • Manufacturing & Supply Chain
    • Customer Service Customer Service
      • FAQs
      • Standard Conditions of Sale
      • Reimbursement
    • Patent Information
  • Pipeline
    • Pipeline Overview
    • Clinical Trials
  • Business Development
    • Business Development
  • Art of Imaging
    • Overview
    • History of Innovation
    • Medical Imaging 101
    • Echocardiography
    • Nuclear Imaging
    •
  • Contact Us
  • Investors
  • Media
  • Careers
    •

    Investor Relations

    Investor Relations

    • Investor Overview
    • Corporate Profile
    • Press Releases
    • SEC Filings
    • Supplemental Financial Information
    • Corporate Governance
    • Board of Directors
    • Committee Composition
    • Stock Information
    • Calendar of Events
    • Presentations
    • Information Requests
    • FAQ
    • IR Contact

    Investor Toolkit

    • Print Page
    • RSS Feeds
    • E-mail Alerts

    Presentations

    Date Title
    05/17/22
    • Add Files
      Investor Day Presentation 7.8 MB
    05/02/22
    • Add Files
      Investor Presentation 5 MB
    04/29/22
    • Add Files
      Q1 2022 Earnings Presentation 50.6 MB
    • 
  • Contact Us
  • Privacy Policy
  • Legal Notice
  • Compliance
  • Suppliers/Vendors
    •

    © 2022 Lantheus Medical Imaging, Inc. All rights reserved.
    Intended for U.S. Residents only.

    331 Treble Cove Road, N. Billerica, MA 01862 Telephone: 1-800-362-2668

    Use of the information on this site is subject to the terms of our Legal Notice and Privacy Policy .